The family of interferon (IFN) regulatory factors (IRFs) encodes DNA-binding transcription factors, some of which function as modulators of virus-induced signaling. The IRF-3 gene is constitutively expressed in many tissues and cell types, and neither virus infection nor IFN treatment enhances its transcription. In infected cells, however, IRF-3 protein is phosphorylated at the carboxyl terminus, which facilitates its binding to the CBP͞p300 coactivator. 
The interferon (IFN) regulatory factors (IRFs) play an important role in virus-and cytokine-induced signaling pathways (1) . The first discovered IRF, IRF-1, was shown to activate the transcriptional activity of the IFNA and IFNB gene promoters, whereas the closely related IRF-2, which binds to the same sequences (IRF-E), generally functions as a repressor (2) , although in the context of some promoters IRF-2 also can be an activator (3) . In addition to IRF-1 and IRF-2, this growing family of transcription factors includes interferon consensus sequence-binding protein (ICSBP), ISGF3␥ (p48), IRF-3, IRF-4 (PIP͞LSIR), IRF-5, IRF-6, and IRF-7. All of these factors share homology in the amino terminus, which contains a DNA-binding domain (DBD) with the five characteristic tryptophan (W) repeats. The carboxyl-terminal regions of these proteins are much less conserved; IRF-1 and IRF-3 were shown to contain a transactivation domain in this region (4) . ICSBP, p48, and IRF-4͞PIP contain in this region an interaction domain, which mediates interaction with other transcription factors (5) (6) (7) .
IFNA and IFNB promoters contain IRF-E within the virus-responsive element (VRE) (2) that play critical roles in virus-mediated inducibility. Transcription of IFNB gene is achieved by synergy among several transcription factors recruited to multiple, distinct DNA-binding sites in the VRE of the IFNB promoter. These factors form a multicomponent transcriptional enhancer complex, the enhanceosome, consisting of ATF2͞c-Jun heterodimer, HMGY(I), NF-B heterodimer, p50͞p65, and IRF and interacting with the components of the general transcriptional machinery through association with the CBP͞p300 coactivator (8, 9) . The proteins regulating the virus-mediated induction of IFNA genes are less well defined; for virus-activated IFNA4 gene expression, two overlapping cis-acting elements (IRF-E and AF-1) are required (10) and point mutation in either site abolished virusmediated activation. Although the presence of the IRF-E site was essential for transcriptional activity, the binding of IRF-1 to IRF-E in the inducible element (IE) of the IFNA4 gene promoter was not detected in the infected cells (11) . In addition, homozygous deletion of IRF-1 in mice did not affect virus-mediated induction of IFNA and IFNB genes (12, 13) , suggesting the possible involvement of other IRFs in these processes. The virus-induced factor that recognizes the IRF-E of the IFNA4 promoter but is distinct from IRF-1, IRF-2, and ISGF3␥ has been described (14, 15) .
We recently found a novel IRF, IRF-3, that binds to the IFN-stimulated response element of interferon-stimulated genes (ISG15) (16) , as well as to IE of the IFNA4 gene promoter and the positive regulatory domain (PRD) III of the IFNB gene promoter (17) . In the transient transfection assay, IRF-3 enhanced the Newcastle disease virus (NDV)-mediated transcriptional activation of the IFNA4 gene promoter (16) in L cells, but not in adenovirus E1A-transformed human kidney 293 cells, where overexpression of IRF-3 inhibited both IRF-1-and NDV-mediated transactivation of IFNA4 promoter. However, a fusion protein, consisting of an IRF-3 DNA-binding domain and relA(p65) activation domain efficiently stimulated transcription activity of the IFNA4 and IFNB promoters in 293 cells, further indicating the presence of IRF-3-binding sites in these promoters (17) and the possible involvement of the carboxyl-terminal part of IRF-3 in differential activation of IFNA4 promoters between infected L929 and 293 cells. Al-though transcription of the IRF-3 gene is not activated by viral infection, the carboxyl-terminal serine residues of IRF-3 protein are phosphorylated in infected cells, and this phosphorylation results in the translocation of IRF-3 to the nucleus and facilitates its binding to CBP͞p300 (18) (19) (20) .
The aim of present study was to further analyze the role of IRF-3 in transcriptional activation of the endogenous IFNA and IFNB genes. We demonstrate that (i) overexpression of IRF-3 in both rat and human fibroblasts enhances the levels of IFN synthesized in virus-induced cells and restricts virus replication; (ii) IRF-3-induced antiviral effects require activation of IFN genes and a functional IFN signaling pathway; and (iii) adenovirus E1A gene product down-modulates IRF-3-mediated transcriptional activation of the IFNA promoter.
MATERIALS AND METHODS
Plasmid Constructs and Oligonucleotides. The IRF-3 expression plasmid was constructed by cloning the SalI-NotI IRF-3 cDNA fragment 3Ј in-frame to hemagglutinin epitope in PHA-2 Hyb plasmid obtained from C. Dang (Johns Hopkins University, Baltimore). Mutant IRF-3 expression plasmids containing deleted proline cluster (amino acids 153-192), amino-terminal, or carboxyl-terminal fragments of IRF-3 were created by PCR and cloned into EcoRI-XhoI sites of pHA-2 Hyb. All plasmids were sequenced before use. The IRF-3(5A) plasmid containing the point mutations in carboxyl-terminal serines (S396A, S398A, S402A, and S504A) and threonine (T404A) was described recently (18) . The IRF-1 and IRF-2 expression plasmids were a gift from T. Taniguchi (University of Tokyo). The indicator plasmids [IFNA4͞chloramphenicol acetyltransferase (CAT) and IFNB͞CAT] were described previously (21, 22 ). An E1A expression plasmid containing 13S E1A gene under the control of RSV promoter and the 12S E1A (⌬p300) mutant that contains a 12-to 36-aa deletion were obtained from D. Kalvakolanu (University of Maryland, Baltimore); p300 expression plasmid was obtained from G. Nabel (23) . CAT and Antiviral Assays. The CAT assays were done as described previously (22) , and CAT activity was normalized to constant transfection efficiency determined by ␤-galactosidase activity. For the antiviral assay, cells were transfected with 5 g of IRF-3 expressing plasmid, and 24 hr after transfection cells were infected with vesicular stomatitis virus (VSV) [multiplicity of infection, 2]. Medium was collected 16 hr after infection, and the number of infectious particles was determined by a plaque assay with L cells as target cells. The levels of IFN in the medium were determined by a biological assay (25) .
RNA Analysis. Total RNA was isolated by the Trizol method (Life Technologies, Gaithersburg, MD). Ten micrograms of total RNA was analyzed by Northern blot hybridization with IFNA-and IFNB-specific riboprobes (26, 27) . For the reverse transcription-PCR (RT-PCR) analysis, 2 g of total RNA was reverse-transcribed to cDNA by using a sequence-specific 3Ј primer. Five microliters of the reaction mixture was PCRamplified by using Taq DNA polymerase (Life Technologies). The primers used for the cDNA synthesis and amplification of rat IFNA RNA were: 5Ј primer ATG GCT CGG CTC TGT GCT and 3Ј primer GCT CTC CAG ACT TCT GCT.
RESULTS

Overexpression of IRF-3 Stimulates Transcription of IFN Gene Promoters and Enhances Virus-Mediated Induction.
We recently showed that the recombinant amino-terminal IRF-3 peptide-(1-133) strongly binds to the IE of IFNA4 gene promoter and to the PRDIII region of the IFNB gene promoter (17) . However, in 293 cells and mouse L cells, overexpression of IRF-3 alone did not enhance expression of IFNA4 or IFNB promoters in transient transfection assays (16, 17) . To determine whether this lack of IRF-3-mediated activation is cell type-specific, IRF-3 expressing plasmid was cotransfected with the IFNA4 CAT reporter plasmid into REFs. The results in Fig. 1A show that overexpression of IRF-3 in these cells stimulated transcriptional activity of IFNA4 promoter; activation of this promoter by IRF-1 or IRF-2 served as positive and negative controls, respectively. Western blot analysis has shown that all the transfected IRFs were expressed at comparable levels (data not shown). We have shown previously that overexpression of IRF-1 enhances virus-mediated induction of IFNA promoter (11) . Overexpression of IRF-3 also greatly enhanced the virus-mediated induction of this promoter, and the effect was more than additive. Both IRF-3 and IRF-1 also stimulated transcriptional activity of IFNB gene promoter, although to a lesser extent, and the synergism between IRF-3 and virus-activated transcription was lower when measured for IFNB promoter (3-to 4-fold enhancement when compared with virus alone) than for IFNA (6-to 7-fold enhancement). Both IRF-2 and ICSBP inhibited constitutive activity of the IFNB promoter.
To define the region of IRF-3 essential for virus-mediated induction of these two promoters, the activation of IFNCAT reporter plasmids by various IRF-3 mutants was examined in the presence or absence of viral infection ( (ii) that the virus-mediated phosphorylation of IRF-3 up-regulates its transactivation activity; and (iii) the IRF-3 phosphorylation mutant IRF-3(5A) retains relatively low transcriptional activity. As shown recently, recombinant IRF-3-(1-133) binds to the 3Ј region of the IE of IFNA4 gene promoter (17) , which contains the IRF-E and shows homology to PRDIII. As shown in Fig. 2D , two mutations in this region, at positions Ϫ103 and Ϫ94, that were shown previously to abolish the virus-activated IFNA promoter, substantially decreased IRF-3-mediated activation of Ϫ452-bp IFNA4 promoter. These results indicate that the GAAANN motif in the IRF-E plays a critical role in IRF-3-mediated transcriptional activation of the IFNA4 promoter.
Overexpression of IRF-3 Enhances Virus-Mediated Induction of Endogenous IFNA and IFNB Genes. In a transient expression assay, IRF-3 enhances NDV-mediated induction of the IFNA and IFNB promoters. To determine whether IRF-3 also can stimulate induction of endogenous IFN genes, the levels of IFN synthesized in infected REF cells transfected with IRF-3 and in the untransfected controls were compared. As seen in Fig. 3A , overexpression of IRF-3 in REF cells enhanced virus-mediated stimulation of IFN synthesis (Fig. 3) by 2-to 3-fold. In contrast, there was no enhancement of IFN synthesis by the IRF-3(5A)-mutant. Western blot analysis of the relative levels of IRF-3 and IRF-3(5A) protein in transfected cells showed that these two proteins were expressed at comparable levels, indicating that the inability of IRF-3(5A) to stimulate IFN synthesis was not a result of the low levels of expression (data not shown). It should be noted that, under conditions of the transient transfection, only about 25-30% of cells were transfected. Thus, because not all cells are transfected, the observed synergism probably is underestimated.
To confirm these observations, the steady-state levels of IFN mRNA induced by NDV in the presence or absence of overexpressed IRF-3 were analyzed. Because the IFNA genes are expressed at very low levels in fibroblast cells upon NDV infection, the relative levels of IFNA mRNAs were evaluated by RT-PCR by using specific primers corresponding to rat IFNA gene (see Proc. Natl. Acad. Sci. USA 95 (1998) show that the relative levels of correctly amplified fragment (marked by arrow) were substantially (about 5-fold) increased in infected IRF-3 expressing cells when compared with infected cells that did not overexpress IRF-3. Similarly, the relative levels of IFNB mRNA, compared by Northern blot analysis, at different times postinfection (Fig. 3C ) were increased by 15-fold in IRF-3 transfected cells. These data suggest that IRF-3 has an important role in virus-mediated induction of both IFNA and IFNB genes. While this paper was being completed, Yoneyama et al. (19) showed that IRF-3 increases virus-mediated induction of IFNA and IFNB genes in L cells. IFN Signaling Pathway Is Critical for IRF-3-Mediated Antiviral Effect. It was shown previously that overexpression of IRF-1 confers an antiviral state that is activated by an IFN-independent pathway (28) . In a transient expression assay in L cells and 293 cells, IRF-3 enhances transcriptional activity of the ISG15 promoter (16, 18) . To determine whether the antiviral effect can be induced by IRF-3 independent of IFN signaling, the human fibroblast line, 2FTGH, and mutant cell lines derived from these cells that lack one of the essential components of the IFN signaling pathway were used (29) . Overexpression of IRF-3 in 2FTGH cells restricted VSV replication by more than 10-fold when compared with replication in 2FTGH cells transfected with the vector DNA (Fig.  4A) . Analysis of the relative levels of IRF-3 in transfected 2FTGH cells shows the presence of IRF-3 in both the cytoplasm and nucleus (data not shown). Transfection with plasmid expressing IRF-3 antisense (IRF-3-AS) did not restrict VSV replication, and these cells were even more permissive to virus replication. These results further confirmed that the antiviral state is induced by IRF-3 and not by the transfected DNA. In contrast, overexpression of IRF-3 in U2A cells that have a nonfunctional p48 and thus are unable to form the ISGF3 transcriptional complex, or in U4A cells that are defective in JAK1 function, did not result in inhibition of VSV replication. Both of these cells are insensitive to the antiviral effect of IFN.
By Northern hybridization, the presence of IFNB mRNA in IRF-3-transfected 2FTGH cells was detected, whereas no induction of IFNB mRNA was observed in cells transfected only with DBD of IRF-3 (amino acids 1-115) (Fig. 4B) . Also, overexpression of IRF-1 did not induce expression of the IFNB gene in these cells. Under the same conditions, neither IRF-3 nor IRF-1 induced detectable levels of IFNA mRNA (data not shown). Taken together, these data indicate that the antiviral effect of IRF-3 requires a functional IFN signaling pathway and that, in 2FTGH cells even in the absence of viral infection, IRF-3 can be detected in the nucleus and can stimulate the transcription of IFNB, but not IFNA genes. However, because the expression of IFNA genes in these cells is not stimulated (or very little) even by viral infection, we cannot make a general conclusion that IRF-3 does not induce the IFNA genes.
To determine the contribution of direct activation of ISG with antiviral activity to the IRF-3-mediated induction of the antiviral state, Vero cells, which are sensitive to the antiviral effect of IFN but lack the endogenous IFNA and IFNB genes, were used. Because viral infection of Vero cells nonetheless can stimulate expression of the exogenously introduced IFNB promoter, this indicates that the viral-mediated signaling that leads to the activation of IFNB gene is not impaired in these cells (21) . As shown in Inhibition of IRF-3-Mediated Transactivation by E1A. As we have shown previously in 293 cells, IRF-3 was unable to transactivate IFNA and IFNB promoters, and IRF-3 overexpression did not enhance virus-mediated induction of the endogenous IFN genes in these cells (17) . Because these cells express the adenovirus E1A oncogene product that inhibits IFN␣ responses (30), we examined whether E1A can also counteract IRF-3-mediated transactivation. As seen in Fig. 5A , expression of E1A resulted in 94% inhibition of IRF-3-mediated transactivation of the IFNA4 gene promoter, whereas E1A inhibited transactivation by IRF-3(5A) by only 15%. Finally, E1A also inhibited virus-mediated induction of the IFNA4 promoter, as well as the synergistic transactivation by virus and IRF-3 (Fig. 5B) .
The carboxyl-terminal phosphorylation of IRF-3 was shown recently to be important for interaction of IRF-3 with transcriptional adapters p300͞CBP (18, 19) that are targeted by E1A (31) . Transactivation of IFNA4 promoter by IRF-3 was inhibited by cotransfection with the carboxyl-terminal peptide (amino acids 1992-2441) of CBP that contains the IRF-3-binding site (18) (Fig. 5D) . If inhibition by E1A is a result of competition for binding to limiting amounts of p300, then E1A mutant unable to bind p300 should not be inhibitory and overexpression of p300 may be expected to restore IRF-3-mediated transactivation in the presence of E1A. As seen in Fig. 5A , no inhibition of IRF-3 or virus-mediated activation of IFNA4 promoter was detected with E1A mutant [E1A(⌬p300)] being unable to bind the transcriptional adapter p300͞CBP (Fig. 5 A and B) . Furthermore, overexpression of p300 partially reversed the E1A-mediated suppression. That the restoration of IRF-3 activity by p300 was incomplete indicates that an additional mechanism may be involved in E1A-mediated suppression. To exclude the possibility that the inhibitory effect of E1A on IRF-3 transactivation is a result of down-regulation of IRF-3 expression, we analyzed, by Western blot, the levels of IRF-3 in transfected cells in the presence and absence of E1A and found that the levels of IRF-3 were not affected by the presence of E1A (Fig. 5C ).
DISCUSSION
The findings presented in this study show that IRF-3 can strongly enhance virus-stimulated expression of IFN genes in both mouse and human fibroblast cells. As shown previously (18) , virus induces posttranslational phosphorylation of the carboxyl terminus of IRF-3 at residues Ser-396, -398, -402, and -405 as well as Thr-404. Mutations introduced into these phosphorylation sites [IRF-3(5A)] decreased the transactivating ability of IRF-3 by about 50% in a transient transfection assay in both infected and uninfected cells, and further abolished its ability to enhance the endogenous IFN synthesis in infected cells. These data indicate that the virus-induced phosphorylation of IRF-3 modulates transcriptional activity of IRF-3. However, IRF-3 overexpression alone can activate the transcriptional activity of IFNA and IFNB promoters, induce an antiviral state, and stimulate transcription of the endogenous IFNB gene in a cell type-specific manner (unpublished results). These data indicate that, in certain cell types when expressed at high levels, IRF-3 can overcome the requirement for the virus-mediated phosphorylation. Indeed, we have detected the presence of IRF-3 in the nucleus of 2FTGH cells overexpressing IRF-3 (data not shown), and a mouse cell line, in which expression of IRF-3 is regulated transcriptionally, produces high levels of IFN (500 units͞ml) after induction of IRF-3 expression (unpublished results). These findings, together with the observation that mutants of IRF-3 that cannot be phosphorylated retain low transactivation activity, indicate that the basal transactivation activity of IRF-3 may be mediated by its transactivation domain. Nevertheless, the virusmediated carboxyl-terminal phosphorylation of IRF-3 stimulates its transactivation potential, enhances its interaction with the transcriptional coactivator p300͞CBP (18) (19) (20) , and consequently stabilizes the activation complexes. The critical role of p300͞CBP in IRF-3-mediated activation is further supported by three observations: (i) overexpression of the carboxyl-terminal region of CBP that interacts with IRF-3 (18) suppressed the IRF-3-mediated activation; (ii) IRF-3-stimulated activation of IFNA promoter was strongly (95%) inhibited by E1A, which interacts with the C͞H3 domain of p300 as well as with the carboxyl-terminal region of p300 (32, 33) ; and (iii) E1A mutant [E1A(⌬p300)], which does not bind p300, also does not modulate the IRF-3-mediated stimulation of the IFNA4 promoter. These results indicate that, when overexpressed, IRF-3 can bind p300͞CBP. The Western blot analysis of IRF-3 in E1A-expressing cells and in the controls excluded the possibility that E1A targets IRF-3 for degradation. That overexpression of p300 was able to partially revert E1A repression of IRF-3 activity suggests that the inhibition may be a result of the competition for binding of E1A and IRF-3 to p300. The inhibition of IRF-3-mediated activation by E1A implies an alternative mechanism for viral mimicry, where adenovirus can overpass the antiviral effect of IFN by a direct interference with transcription of the IFNA and IFNB genes, in addition to the inhibition of the induction of ISG genes (30) . It was observed previously that E1A inhibits induction of IFNB by double-stranded RNA (dsRNA); however, the mechanism of this inhibition was not clarified (34) .
The finding that many transcription factors activated in virus-infected cells, such as IRF-1, IRF-3, NF-B, and STAT proteins, interact with p300 (23, (35) (36) (37) (38) identifies p300 as an integral component of the virus-induced activation complex. Both IRF-3 and p300 have been found recently in the dsRNAinduced DRAF-1 (dsRNA-activated factor) and VA-IRF (virus-activated IRF) ternary complex that bind to IFNstimulated response element and PRDI, respectively (19, 20) .
Although IRF-1 was shown to effectively stimulate the IFNA4 promoter in transient transfection assays (10, 11) , induction of an antiviral state in cells overexpressing IRF-1 was found to be independent of IFN induction (27) . Also, induction of the ISG-561 gene by dsRNA was found to be a direct effect that requires STAT1, but not the other components of the IFN signaling pathway (44) . In contrast, as shown in the present study, the induction of the antiviral state in cells overexpressing IRF-3 is mainly due to the induction of endogenous IFN genes. The significant enhancement of expression of IFNB genes and IFN synthesis in infected, IRF-3-overexpressing cells suggests that IRF-3 may be the limiting factor that determines the levels of IFN synthesized in infected cells. However, the low levels of IFNA gene expressed in infected fibroblasts could not be increased to the levels induced in infected B cells or macrophages (data not shown) by overexpression of IRF-3, suggesting a requirement for another, possibly lymphoid cell-specific, transcription factor(s). We have identified previously two proteins of 68 and 96 kDa that bind to the AF1 site of IFNA promoter (10) , and ISGF3␥ (p48) was implied to play a role in the induction of both IFNA and IFNB genes (39) . Thus, the transcriptional activation of IFNA genes may require synergy among multiple transcription factors, such as that proposed for the IFNB gene promoter (8, 9, 40, 41 ). An important function of IRF-3 in the activation of endogenous IFN genes may relate to its ability to recruit CBP͞p300 to the IFN enhanceosome. Several studies have now demonstrated the critical role of histone acetyltransferase activity of CBP͞p300 and its associated factors (42) in the destabilizing and remodeling of nucleosomes and improving the accessibility of transcription factors to their DNA targets (43) . While this paper was being reviewed, it was shown (45) that IRF-3 may indeed be a component of the enhanceosome that binds to the IFNB gene promoter.
In conclusion, the present studies have established that IRF-3 plays a direct role in virus-mediated signaling and have identified a mechanism by which IRFs modulate transcriptional activity of the endogenous genes. These studies also provide further evidence that interaction between transcriptional factors and the p300͞CBP coactivator is essential for the integration of their functional activity in response to viral infection and that an alteration of these interactions by a virus-encoded protein may represent a novel mechanism by which some viruses down-regulate the transcription of the antiviral genes.
